• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • South Asia

Deal focus: Patience pays off for True North

  • Holden Mann
  • 06 March 2019
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

True North realizes a two-year goal with the acquisition of a controlling stake in Indian health insurance provider Max Bupa

True North’s last foray into India’s health insurance space occurred in 2017 when it led a consortium to acquire Religare Health Insurance. It would have been the first private equity buyout of a health insurance firm in the country, but the buyers found they were still a bit too far ahead of their time.

“There were no guidelines from the insurance regulator about a PE firm taking control of a health insurance company. It wasn’t until nearly seven months after our signing that these regulations came out,” says Divya Sehgal, a partner at True North. “Unfortunately, that was too long, and we weren’t able to go through with the transaction.” 

No such obstacle blocked the firm in its return to the space with the acquisition of a 51% stake in Max Bupa Health Insurance for INR5.1 billion ($72 million). Now True North plans to use the company’s solid foundation to build it into one of India’s leading health insurance providers.

The groundwork for the acquisition of Max Bupa was prepared several years ago, when True North – then called India Value Fund Advisors – reached out to Analjit Singh, founder of Indian conglomerate Max Group. Singh was thinking about rebalancing Max Group’s portfolio, and eventually decided it was time to divest Max Bupa, the conglomerate’s joint venture with global insurance giant Bupa Group.

True North immediately put its name forward to acquire Max Group’s stake in the business. The company was appealing on a pure business level: it was already one of India’s largest health insurance providers, and growth still outpaced the industry average. In addition, Bupa could not simply buy the Max Group holding because insurance firms to be at least 51% Indian-owned.

“Brand, retail distribution, and the quality of the book are what we evaluated this platform on, and on these themes Max Bupa has perhaps the best pedigreed shareholders in the health insurance space today,” Sehgal says. “This is a platform that has been around for 10-12 years, it’s invested in each of these three factors, and we felt we could acquire it and take it to the next stage.”

The company will continue to use Bupa branding while the Max name is phased out over the next few years. True North plans to emphasize Max Bupa’s strengths to help it maintain leadership in a domestic insurance market that is underpenetrated yet expected to see rapid expansion in coming years as incidence of chronic diseases increases and customers become more familiar with the product.

“Health insurance is in a bit of a land grab phase right now. I expect that will settle down over a five or six-year period, and the growth rate of the industry will normalize, but while the tailwinds last this organization will continue its high growth rate,” says Sehgal. “One of the strengths of the platform is that it’s 97% retail. It doesn’t do that much group business, and we like that.”

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • South Asia
  • Financials
  • Buyouts
  • India
  • True North
  • insurance
  • Financial Services

More on South Asia

india-rupee-money-nbfc
India's InCred announces $60m round, claims unicorn status
  • South Asia
  • 10 Nov 2023
india-baby
Beauty brand Mamaearth raises $204m in India IPO
  • South Asia
  • 09 Nov 2023
doctor-stethoscope
Norwest backs India hospital, HealthQuad marks 3x exit
  • South Asia
  • 08 Nov 2023
xpressbees
OTPP invests $80m in India's Xpressbees
  • South Asia
  • 08 Nov 2023

Latest News

world-hands-globe-climate-esg
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
housing-house-home-mortgage
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
india-rupee-money-nbfc
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
roller-mark-luke-finn
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013